Detection of circulating tumor cells and PTEN loss in localized prostate cancer before and after radical prostatectomy: Prognostic implications and predictors of treatment response. Secondary outcomes ...

Prostate cancer is the most common malignant tumor in men, accounting for 29% of male neoplasm diagnoses in the United States alone. Radical prostatectomy remains the preferred treatment for localized ...

A prostatectomy is surgery to partially or completely remove the prostate gland to treat conditions such as prostate cancer or benign prostatic hyperplasia (BPH). A radical prostatectomy is the ...

Among men with PSA persistence after radical prostatectomy, a higher preoperative PSA surprisingly was linked to lower mortality. Men with PSA persistence and preoperative PSA >20 ng/mL had 31% lower ...

Stereotactic body radiotherapy as salvage therapy after radical prostatectomy was well tolerated. Toxic effects were comparable to a historical cohort of patients receiving conventionally fractionated ...

Among men with high-risk localized prostate cancer, those receiving neoadjuvant apalutamide combination therapy had improved potency recovery by 12 months and reduced rates of positive margins ...

Testosterone replacement therapy improved function without PSA recurrence in prostate cancer survivors with hypogonadism. Learn more.

Impact of a rash management guide on incidence and severity of rash with apalutamide: Experience from the Apa-RP study in high-risk localized prostate cancer. This is an ASCO Meeting Abstract from the ...

Findings seen over three months in men with low-grade prostate cancer, hypogonadism treated with radical prostatectomy.